EDETATE DISODIUM ANHYDROUS

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
289.0 -8.8 1 9 168.0 11 0.6
UNII
8NLQ36F6MM
CAS
139-33-3
SYNONYMS
  • Disodium (ethylenedinitrilo)tetraacetate
  • Edetate Disodium Anhydrous
  • Edetate Disodium Anhydrous [ii]
  • Edta Disodium Salt [mi]
  • Chelatran
  • Endrate Disodium
  • Edetate Disodium [who-Dd]
  • Anhydrous Disodium Edetate
  • Disodium Edta
  • Nsc-2760
ZINC ID(s)
Availability
Present in 83 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).
Name Description Classification
BLAVIM VIM-1 protein Unclassified / Unclassified

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT01101412 Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Phase 1/Phase 2 Withdrawn
NCT02300376 2014-12-01 Designing a Bayesian Model of the Plasma Clearance of Calcium Edetate de Sodium for the Calculation of GFR and Validity Compared to the Renal Clearance of Inulin Phase 3 Not Yet Recruiting
NCT02286258 2014-10-01 Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR) Phase 1/Phase 2 Recruiting
NCT01588756 2010-10-01 Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2) Phase 1/Phase 2 Recruiting
NCT01118663 2010-09-01 Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection Phase 3 Terminated
NCT00044213 2003-09-01 Trial to Assess Chelation Therapy (TACT) Phase 3 Completed

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
Intra-Amniotic Injection
Intramuscular Injection
Intravenous Injectable
Intravenous Injection
Iv(infusion) Injection
Ophthalmic Solution

More Information

Usage Over Time

Comments